Well worth a watch- a lot of
confidence around the near term contracts with insurers and accountable care organisations. seems almost. retain they will sign up for trials. The trial sizes alone will boost revenue significantly.
He gives a good explanation of how the cost savings work for these organisations and the low target for readmission prevention that RSH needs to provide to meet the requirement for a
full contract to follow.
Well worth a watch- a lot ofconfidence around the near term...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
